Soybean oil 20 % Injectable Suspension
RxNorm 200317
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 200317 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: soybean oil 20 % Injectable Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Soybean oil 200 mg/ML Injectable Suspension
(Atom ID: 12325031)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely Glycine max oil refined 200 mg/1 mL conventional release emulsion for infusion (clinical drug)
(Atom ID: 12756887)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely Glycine max oil refined 200 mg/1 mL conventional release emulsion for injection (clinical drug)
(Atom ID: 12756889)
SYPrescribable
Synonym (SY):
Soya bean oil refined 200 mg/mL emulsion for infusion
(Atom ID: 12757720)
SYPrescribable
Synonym (SY):
Soya bean oil refined 200 mg/mL emulsion for injection
(Atom ID: 12757722)
PSNPrescribable
Prescribable Name (PSN):
Soybean oil 20 % Injectable Suspension
(Atom ID: 7246169)
SYPrescribable
Synonym (SY):
Soybean oil 20 % Injectable Suspension
(Atom ID: 7246175)
PTPrescribable
Designated preferred name (PT):
Soybean oil refined 200 mg/mL emulsion for infusion
(Atom ID: 12537914)
PTPrescribable